The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples

Study findings shed light on effective new HCV therapy that will treat patients who have failed other therapies

MP Biomedicals announced it has received CE Marking (Conformite Europeenne) in the European Union for its innovative multiparameter patented Hepatitis C test - MULTISURE HCV antibody test.

The National Medical Association 110th Annual Convention and Scientific Assembly in New Orleans, Louisiana

The Viral Hepatitis Testing Act of 2011 was introduced in both Houses of Congress today potentially saving billions in taxpayer dollars.